SRZN.NASDAQSurrozen, Inc/de

SCHEDULE: Column Group Adjusts Stake in Surrozen, Inc.

Sentiment:

Beneficial Ownership Filing (Schedule 13D Amendment)


The Column Group entities and individuals have updated their beneficial ownership filings for Surrozen, Inc., reflecting changes in their holdings and the overall share count.

Capital raiseThe filing references Surrozen, Inc.'s private placement transaction, which involved the sale of additional shares of common stock.The reporting persons are acquiring shares in the second tranche of this private placement transaction.

Summary

  • This filing is an amendment to a previous Schedule 13D, updating the beneficial ownership of Surrozen, Inc. common stock by various entities and individuals associated with The Column Group.
  • The primary reason for the amendment is dilution caused by Surrozen, Inc.'s sales of additional shares of common stock since the original filing.
  • The reporting persons include The Column Group III, LP, The Column Group III-A, LP, The Column Group III GP, LP, The Column Group Opportunity III, LP, The Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Tim Kutzkey, and Peter Svennilson.
  • These entities and individuals collectively hold a significant stake in Surrozen, Inc., with Tim Kutzkey and Peter Svennilson each beneficially owning 3,824,612 shares, representing 29.3% of the outstanding common stock.
  • The holdings include shares held directly, shares to be acquired within 60 days from a private placement, and warrants exercisable within 60 days.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily an administrative update reflecting changes in ownership percentage due to dilution and ongoing investment activities rather than a significant strategic development.

Positives

  • The Column Group entities and individuals maintain a substantial beneficial ownership in Surrozen, Inc., indicating continued investment and confidence.
  • The reporting persons are actively managing their stake and updating filings as required, demonstrating compliance with regulatory requirements.
  • The inclusion of shares from private placements and exercisable warrants suggests potential for increased ownership and participation in the company's growth.

Negatives

  • The need for this amendment is due to dilution from the company's sales of additional shares, which reduces the reporting persons' percentage ownership.
  • Certain warrants held by TCG III LP, TCG III-A LP, and TCG Opportunity III LP are not exercisable within 60 days due to beneficial ownership limitations, restricting immediate increases in stake.

Risks

  • Dilution from future share sales by Surrozen, Inc. could further decrease the reporting persons' percentage ownership.
  • Beneficial ownership limitations on certain warrants may prevent timely exercise and increase in shareholding.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from Surrozen, Inc. It primarily serves to update beneficial ownership information.

Industry Context

StockSavvy.ai notes that this Schedule 13D amendment reflects typical adjustments by venture capital firms in response to corporate actions like private placements and subsequent dilution, a common occurrence in the biotechnology and life sciences sectors where Surrozen, Inc. operates.

Stakeholder Impact

  • Shareholders: The dilution mentioned in the filing may impact existing shareholders by reducing their proportional ownership and potentially affecting share value if not accompanied by positive company performance.
  • The Column Group entities: As significant investors, their updated stake and potential future acquisitions are relevant to their investment strategy and performance.
  • Surrozen, Inc. Management and Board: The continued significant ownership by The Column Group, including a board member (Tim Kutzkey), indicates ongoing investor oversight and potential influence.

Next Steps

  • The reporting persons will continue to monitor Surrozen, Inc.'s activities and may adjust their holdings further.
  • Future share sales by Surrozen, Inc. could lead to additional amendments to this filing.

Key Dates

DateDescription
2021-08-23Original Schedule 13D filing date.
2023-02-13Filing date of Amendment No. 1.
2024-04-08Filing date of Amendment No. 2.
2024-04-17Filing date of Amendment No. 3.
2025-03-28Filing date of Amendment No. 4 and disclosure of Issuer's Current Report on Form 8-K regarding private placement.
2026-01-22Filing date of Amendment No. 5.
2026-03-19Date as of which shares of Common Stock outstanding were reported by the Issuer.
2026-03-23Date of Issuer's annual report on Form 10-K.
2026-03-26Date as of which shares of Common Stock outstanding were reported by the Issuer.
2026-03-28Date of Issuer's Current Report on Form 8-K disclosing private placement.
2026-05-15Date of Amendment No. 6 filing.

Keywords

Surrozen, Inc., Schedule 13D, Beneficial Ownership, The Column Group, Venture Capital, Common Stock, Dilution, Warrants, Private Placement, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.